post-covid syndrom
Conditions
Interventions
Group 1: patients with post-covid condition in inpatient psychosomatic treatment
Intervention:
- Psychotherapy: individual therapy, psychoeducational guided open-ended interaction group, mindfulness t
Sponsors
Psychosomatische und Psychotherapeutische Abteilung, Universitätsklinikum Erlangen
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1) PCR-confirmed SARS-Cov-2 infection and subsequent PASC: complaints that are still present more than 12 weeks after the onset of SARS-Cov-2 infection and cannot be explained otherwise 2) Written informed consent to participate in the study 3) Sufficient knowledge of the German language to participate in the study 4) Treatment group: indication for inpatient psychosomatic treatment due to: - A clinically relevant psychiatric diagnosis - Limitations that significantly reduce the ability to manage everyday life (e.g. the ability to maintain daily structure) and/ or - Subjective stress so great that the quality of life and everyday resilience are significantly limited 5) Control group: depressive symptoms in self-assessment (PHQ-9 = 10)
Exclusion criteria
Exclusion criteria: - Severely physically impaired patients (predominantly bedridden) - Unique or main diagnosis of substance abuse (F10 – F19), schizophrenia, psychosis (F20 – F229) or organic psychiatric disorders (F00 – F09) - Suicidality - Control group: utilization of PASC-specific outpatient or inpatient psychotherapeutic treatment or psychosomatic rehabilitation during 5 weeks of treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| symptoms of post-covid syndrom assessed with the post-covid syndrom score (PCS) | — |
Secondary
| Measure | Time frame |
|---|---|
| Measurement time points: - Time of admission to inpatient setting (T0) - Time of discharge from the inpatient setting (T1) - Catamnesis (after 6 months) (T2) measuring instruments: - web-based questionnaire battery (T0, T1 and T2): Fatigue assessed with the Fatigue Severity Scale (FSS) Post-exertionel-malaise measured with the PEM Sleep disorders measured with Insomnia Severtiy Index (ISI) Depression assessed with the Patient Health Questionnaire for depression (PHQ-15) Generalized anxiety measured with the Generalized Anxiety Disorder (GAD-7) Somatic symptoms measured with the Patient Health Questionnaire (PHQ-9) Social support measured with the Enriched Social Support Inventory (ESSI, social support) Sense of Coherence measured with the Sense of Coherence Scale (SOC-3) Subjective experience of stress measured with the Perceived Stress Scale (PSS -4) Psychological stress in somatic stress disorder assessed with the Somatic Symptom Disorder (SSD-12) Patient Competence in Coping with Illness Questionnaire (PUK-2) (= a version of the Patient Competence in Coping with Cancer Questionnaire, PUK, adapted for post-Covid symptoms) In addition, socio-demographic data, medication and use of previous treatments as well as data on the patient's health behavior (e.g. smoking, alcohol consumption, etc.) are collected - on presentation in the inpatient setting and on discharge (T0 and T1), detailed laboratory parametric examinations (differential blood count, immunological tests to clarify inflammation parameters) and examinations of lung function and heart function (ECG) are also carried out - At T2 (catamnesis), patients also receive the following questionnaires: Questions on satisfaction with the psychosomatic inpatient treatment, ability to work, questions on personality and use of post-Covid-specific treatments (medication, etc.) in the meantime (self-constructed) - neuropsychological examination: Assessment of declarative verbal | — |
Countries
Germany
Contacts
Public ContactYesim Erim
Psychosomatische und Psychotherapeutische Abteilung, Universitätsklinikum Erlangen
Outcome results
None listed